PTO- 1478 |
Approved for use through 05/31/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90768935 |
Filing Date: 06/11/2021 |
Input Field |
Entered |
SERIAL NUMBER | 90768935 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\907\689\90768935\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | PYRUKYND |
COLOR MARK | YES |
COLOR(S) CLAIMED (If applicable) |
The color(s) purple, fuchsia, chartreuse and turquoise is/are claimed as a feature of the mark. |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of four check designs joined at their bottoms, forming a stylized starburst shape, in the colors purple, fuchsia, chartreuse, and turquoise, above and to the left of the word pyrukynd in stylized purple lettering. |
PIXEL COUNT ACCEPTABLE | NO |
PIXEL COUNT | 950 x 331 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Agios Pharmaceuticals, Inc. |
*MAILING ADDRESS | 8 Sidney Street |
*CITY | Cambridge |
*STATE (Required for U.S. applicants) |
Massachusetts |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
02139-4169 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, sickle cell disease, pyruvate kinase deficiency (PKD), beta thalassemia and/or alpha thalassemia, genetically defined diseases affecting red blood cells, hereditary spherocytosis, hereditary elliptocytosis, dyserythropoiesis, hemolytic anemia, and other anemias |
FILING BASIS | SECTION 1(b) |
ADDITIONAL STATEMENTS SECTION | |
ACTIVE PRIOR REGISTRATION(S) | The applicant claims ownership of active prior U.S. Registration Number(s) 6302036. |
ATTORNEY INFORMATION | |
NAME | Michael A. Lisi |
ATTORNEY DOCKET NUMBER | 232.026075 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Bridge Intellectual Property Services PLLC |
STREET | 23716 Woodward Avenue |
CITY | Pleasant Ridge |
STATE | Michigan |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 48069-1130 |
PHONE | 248-284-4091 |
FAX | 248-284-4091 |
EMAIL ADDRESS | info@bridgeip.net |
OTHER APPOINTED ATTORNEY | Jennifer Sheehan Anderson |
CORRESPONDENCE INFORMATION | |
NAME | Michael A. Lisi |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | info@bridgeip.net |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /Michael A. Lisi/ |
SIGNATORY'S NAME | Michael A. Lisi |
SIGNATORY'S POSITION | Attorney of record, Michigan bar member |
SIGNATORY'S PHONE NUMBER | 248-284-4091 |
DATE SIGNED | 06/11/2021 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 05/31/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90768935 |
Filing Date: 06/11/2021 |
The applicant's current Correspondence Information: |
Michael A. Lisi |
PRIMARY EMAIL FOR CORRESPONDENCE: info@bridgeip.net SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|